Literature DB >> 11549311

WHSC1L1, on human chromosome 8p11.2, closely resembles WHSC1 and maps to a duplicated region shared with 4p16.3.

I Stec1, G J van Ommen, J T den Dunnen.   

Abstract

We have identified and characterized a gene (60% on protein level) and a pseudogene (93% on DNA level) that show high similarity to the Wolf-Hirschhorn syndrome candidate gene-1 (WHSC1). These genes, WHSC1L1 and WHSC1L2P, map to human chromosomes 8p11.2 and 17q21, respectively. WHSC1L1 is ubiquitously expressed and, like WHSC1, generates two major transcripts, a short (s-type) and a long (l-type). The WHSC1L1 l-type transcript encodes a 1437-amino-acid protein containing 2 PWWP (proline-trypto-phan-proline-tryptophan) domains, 5 PHD (plant-home-domain)-type zinc finger motifs, a SAC (SET-associated Cys-rich) domain, and a SET (Suppressor of Variegation, Enhancer of Zeste and Trithorax) domain. The s-type transcript encodes a protein of 645 amino acids containing a PWWP domain only. WHSC1L2P is an unexpressed, intronless pseudogene of a WHSC1L1 s-type transcript. The 8p11.2 region around WHSC1L1 contains a set of genes including TACC1, FGFR1, LETM2, and WHSC1L1, which seems to be derived from a recent duplication involving 4p16.3 where a similar set of genes is located. Rearrangements of 8p are frequently found in human cancer, including breast cancer. These characteristics indicate that WHSC1L1 might have a role in embryonic development and, when disregulated, in cancer development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11549311     DOI: 10.1006/geno.2001.6581

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  16 in total

1.  Discovery of transcription factors and other candidate regulators of neural crest development.

Authors:  Meghan S Adams; Laura S Gammill; Marianne Bronner-Fraser
Journal:  Dev Dyn       Date:  2008-04       Impact factor: 3.780

Review 2.  The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer.

Authors:  Richard L Bennett; Alok Swaroop; Catalina Troche; Jonathan D Licht
Journal:  Cold Spring Harb Perspect Med       Date:  2017-06-01       Impact factor: 6.915

3.  Development of mammary hyperplasia, dysplasia, and invasive ductal carcinoma in transgenic mice expressing the 8p11 amplicon oncogene NSD3.

Authors:  Brittany Turner-Ivey; Ericka L Smith; Alex C Rutkovsky; Laura S Spruill; Jamie N Mills; Stephen P Ethier
Journal:  Breast Cancer Res Treat       Date:  2017-05-08       Impact factor: 4.872

4.  Genotype-phenotype association studies of chromosome 8p inverted duplication deletion syndrome.

Authors:  Gene S Fisch; Ryan Davis; Janey Youngblom; Jeff Gregg
Journal:  Behav Genet       Date:  2011-01-23       Impact factor: 2.805

5.  Transforming properties of 8p11-12 amplified genes in human breast cancer.

Authors:  Zeng-Quan Yang; Gang Liu; Aliccia Bollig-Fischer; Craig N Giroux; Stephen P Ethier
Journal:  Cancer Res       Date:  2010-10-12       Impact factor: 12.701

6.  Amplified loci on chromosomes 8 and 17 predict early relapse in ER-positive breast cancers.

Authors:  Erhan Bilal; Kristen Vassallo; Deborah Toppmeyer; Nicola Barnard; Inga H Rye; Vanessa Almendro; Hege Russnes; Anne-Lise Børresen-Dale; Arnold J Levine; Gyan Bhanot; Shridar Ganesan
Journal:  PLoS One       Date:  2012-06-13       Impact factor: 3.240

Review 7.  Exploring the developmental mechanisms underlying Wolf-Hirschhorn Syndrome: Evidence for defects in neural crest cell migration.

Authors:  Erin L Rutherford; Laura Anne Lowery
Journal:  Dev Biol       Date:  2016-10-21       Impact factor: 3.582

8.  Optimal ratio of transcription factors for somatic cell reprogramming.

Authors:  Go Nagamatsu; Shigeru Saito; Takeo Kosaka; Keiyo Takubo; Taisuke Kinoshita; Mototsugu Oya; Katsuhisa Horimoto; Toshio Suda
Journal:  J Biol Chem       Date:  2012-09-06       Impact factor: 5.157

9.  KAT6A, a chromatin modifier from the 8p11-p12 amplicon is a candidate oncogene in luminal breast cancer.

Authors:  Brittany Turner-Ivey; Stephen T Guest; Jonathan C Irish; Christiana S Kappler; Elizabeth Garrett-Mayer; Robert C Wilson; Stephen P Ethier
Journal:  Neoplasia       Date:  2014-08       Impact factor: 5.715

10.  Amplification of WHSC1L1 regulates expression and estrogen-independent activation of ERα in SUM-44 breast cancer cells and is associated with ERα over-expression in breast cancer.

Authors:  Jonathan C Irish; Jamie N Mills; Brittany Turner-Ivey; Robert C Wilson; Stephen T Guest; Alexandria Rutkovsky; Alan Dombkowski; Christiana S Kappler; Gary Hardiman; Stephen P Ethier
Journal:  Mol Oncol       Date:  2016-02-27       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.